UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.92 | -0.92 |
| Q1 2022 | 2022-05-10 | -0.71 | -0.71 |
| Q4 2021 | 2022-03-01 | -0.82 | -0.82 |
| Q3 2021 | 2021-11-09 | -0.68 | -0.68 |
| Q2 2021 | 2021-08-09 | -0.70 | -0.70 |
| Q1 2021 | 2021-05-12 | -0.64 | -0.64 |
| Q4 2020 | 2021-03-15 | -0.43 | -0.43 |
| Q2 2020 | 2020-08-10 | -1.23 | -0.30 |
| Q1 2020 | 2020-06-08 | 0.00 | -0.17 |
| 2014-11-25 | Downgrade | ROTH Capital | Buy to Neutral | |
| 2014-11-25 | Boost Price Target | Credit Suisse | Neutral | $9.00 to $20.00 |
| 2014-11-25 | Downgrade | Roth Capital | Buy to Neutral | |
| 2014-11-25 | Downgrade | KBC Securities | Buy to Hold | $17.00 to $19.80 |
| 2014-11-25 | Boost Price Target | Credit Suisse Group AG | Neutral | $9.00 to $20.00 |
| 2014-10-20 | Upgrade | JPMorgan Chase & Co. | Underweight to Overweight | $4.40 to $18.00 |
| 2014-10-13 | Upgrade | KBC Securities | Accumulate to Buy | $11.00 to $17.00 |
| 2014-09-24 | Initiated Coverage | Credit Suisse | Neutral | $9.00 |
| 2014-08-01 | Initiated | Oppenheimer | Outperform | $25 |
| 2014-07-31 | Initiated Coverage | Oppenheimer | Outperform | $25.00 |
| 2014-07-31 | Initiated Coverage | Oppenheimer Holdings Inc. | Outperform | $25.00 |
| 2014-07-28 | Upgrade | Roth Capital | Neutral to Buy | $12.00 to $17.00 |
| 2014-06-18 | Initiated Coverage | Roth Capital | Neutral | $12.00 |
| 2014-06-04 | Upgrade | KBC Securities | Hold to Accumulate | $7.00 to $11.00 |
| 2014-05-02 | Upgrade | KBC Securities | Reduce to Hold | |
| 2014-03-05 | Boost Price Target | Citigroup Inc. | $4.00 to $7.50 | |
| 2014-02-11 | Upgrade | Wedbush | Neutral to Outperform | $7.00 to $12.00 |
| 2014-01-06 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | |
| 2013-09-24 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $35.00 to $6.50 |
| 2013-09-23 | Downgrade | Wedbush | Outperform to Neutral | $50.00 to $7.00 |
| 2013-09-23 | Downgrade | Citigroup Inc. | Buy to Neutral | |
| 2013-09-20 | Lower Price Target | Leerink Swann | $35.00 to $11.00 |
| 2014-11-25 | Downgrade | ROTH Capital | Buy to Neutral | |
| 2014-11-25 | Boost Price Target | Credit Suisse | Neutral | $9.00 to $20.00 |
| 2014-11-25 | Downgrade | Roth Capital | Buy to Neutral | |
| 2014-11-25 | Downgrade | KBC Securities | Buy to Hold | $17.00 to $19.80 |
| 2014-11-25 | Boost Price Target | Credit Suisse Group AG | Neutral | $9.00 to $20.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RNA 90 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| RTW INVESTMENTS, LLC | 5.17M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.17M |
| BlackRock Inc. | 4.12M |
| FMR LLC | 3.47M |
| EcoR1 Capital, LLC | 2.90M |
| Vanguard Group, Inc | 2.70M |
| FEDERATED INVESTORS INC /PA/ | 2.48M |
| RA CAPITAL MANAGEMENT, LLC | 2.17M |
| Cormorant Asset Management, LLC | 2.01M |
| STATE STREET CORP | 1.76M |
| venBio Select Advisor LLC | 1.45M |
| Boxer Capital, LLC | 1.12M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94M |
| Alethea Capital Management, LLC | 0.84M |
| DIMENSIONAL FUND ADVISORS LP | 0.66M |
UM